Credo Diagnostics Biomedical Pte. Ltd., a groundbreaking point-of-care rapid molecular diagnostic company, announced today they will attend the Medlab Middle East exhibition that will take place at the Dubai World Trade Centre from February 3 to February 6.
Credo Diagnostics Biomedical will be showcasing it product line of point-of-care molecular diagnostic solution including the VitaPCR™ platform and Influenza A&B assay, the new QubeMDx+ platform and assays, as well as the upcoming fastest auto-extractor in the world, the Purexon.
Credo Diagnostics Biomedical will be located at the booth #Z4.D29, where they will be meeting with individual practitioners, laboratory technicians, scholars, and potential business partners.
Expanding Companion Animal Molecular Diagnostics for Emerging Infectious Disease Challenges
May 5, 2026
Credo Diagnostics Biomedical is pleased to announce the expansion of the QubeMDx+™ veterinary molecular diagnostics portfolio with four new assays designed to support the detection
